Zerigo Health Raises $43 Million in Series B Funding

Zerigo Health, a Serra Capital III portfolio company, announced a $43 million Series B investment on October 21. This funding will drive adoption of the industry’s only connected light therapy solution which is used to treat chronic skin conditions.

To view the full article, follow here.

Previous
Previous

Remote Patient Monitoring (RPM) Set to Become New Standard of Care

Next
Next

Potential of Artificial Intelligence Replacing Animal Testing in the Future with VerisimLife